Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 6Phase 3 4Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Completed 19Unknown 12Active not recruiting 9Terminated 8Recruiting 6Withdrawn 5Not yet recruiting 4

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 3Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 3Uterine Neoplasms 1Rhabdomyosarcoma 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Brachytherapy × Clear all
NCT07276360 2026-03-27

HypoRTCx-UG

Uganda Cancer Institute

Phase 2 Recruiting
278 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

University of Kentucky

Phase 2 Recruiting
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT07232654 2025-12-01

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07152678 2025-09-03

BRIGHT-ESCC

National Taiwan University Hospital

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06023641 2025-08-19

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

St. Jude Children's Research Hospital

Phase 2 Recruiting
135 enrolled
Sarcoma

Rhabdomyosarcoma

NCT03290534 2025-04-04

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 2 Recruiting
40 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡